Home » Topics » BioWorld Science

BioWorld Science
RSS

End-of-phase II meeting held for HspE7

July 9, 2004

trans-ISA-247 completes single ascending dose study

July 9, 2004

Chiron acquires Sagres Discovery

July 9, 2004

FDA approves new dosing options for Prevacid SoluTab

July 9, 2004

Nycomed terminates Oxygent license agreement

July 9, 2004

Gastric and intestinal protectants claimed in Altana patent

July 8, 2004

PDE4 inhibitors prepared and tested at elbion

July 8, 2004

Modulators of tyrosine kinase-mediated signal transduction disclosed in patent

July 8, 2004

Boehringer Ingelheim patent describes series of cytokine inhibitors

July 8, 2004

Novel DPP-IV inhibitors claimed by Boehringer Ingelheim

July 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...